Healthcare & Life Sciences News and Articles

Google News – Clinical Trials External News

Kalshi to allow bets on clinical trials, FDA decisions - Reuters

news.google.com · 16 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA’s adequate provision rule proposal could accelerate pharma’s transition away from TV - mmm-online.com

news.google.com · 16 Jul 2026

Google News – Biopharma External News

Umoja Biopharma Wins FDA IND Clearance for First CD22-Directed In Vivo CAR T Therapy - BioPharm International

news.google.com · 16 Jul 2026

Google News – Digital Health External News

Bridging the Digital Prevention Gap: A Systematic Literature Review of Digital Health Literacy and Preventive Health Behaviors in Low-Income Communities - Cureus

news.google.com · 16 Jul 2026

Google News – Clinical Trials External News

Kalshi Is Letting People Bet On Clinical Trials And FDA Drug Decisions - Forbes

news.google.com · 16 Jul 2026

Google News – Pharmaceuticals External News

ORASIS PHARMACEUTICALS ANNOUNCES AUSTRALIA SUBMISSION OF A NEW DRUG APPLICATION FOR BESKA FOR THE TREATMENT OF PRESBYOPIA - PR Newswire

news.google.com · 15 Jul 2026

Google News – Medical Devices External News

Watch J&J Declines on Disappointing Demand for Medical Devices - Bloomberg.com

news.google.com · 15 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA plans to release more drug rejection letters as controversial policy resumes - Fierce Biotech

news.google.com · 14 Jul 2026

Google News – FDA (biotech/pharma) External News

“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Pharmaceutical Technology

news.google.com · 13 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - fiercepharma.com

news.google.com · 13 Jul 2026

Google News – Oncology External News

GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win - Fierce Pharma

news.google.com · 13 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca - Fierce Pharma

news.google.com · 10 Jul 2026

Google News – FDA (biotech/pharma) External News

FDA takes first step toward ‘de facto’ ad ban: What to know - MM+M - Medical Marketing and Media

news.google.com · 10 Jul 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

Kalshi to allow bets on clinical trials, FDA decisions - Reuters

FDA’s adequate provision rule proposal could accelerate pharma’s transition away from TV - mmm-online.com

Umoja Biopharma Wins FDA IND Clearance for First CD22-Directed In Vivo CAR T Therapy - BioPharm International

Bridging the Digital Prevention Gap: A Systematic Literature Review of Digital Health Literacy and Preventive Health Behaviors in Low-Income Communities - Cureus

Kalshi Is Letting People Bet On Clinical Trials And FDA Drug Decisions - Forbes

ORASIS PHARMACEUTICALS ANNOUNCES AUSTRALIA SUBMISSION OF A NEW DRUG APPLICATION FOR BESKA FOR THE TREATMENT OF PRESBYOPIA - PR Newswire

Watch J&J Declines on Disappointing Demand for Medical Devices - Bloomberg.com

FDA plans to release more drug rejection letters as controversial policy resumes - Fierce Biotech

“Hub-and-spoke” drug manufacturing set to benefit from new FDA rule - Pharmaceutical Technology

FDA's latest onshoring move homes in on streamlined facility registration, foreign plant scrutiny - fiercepharma.com

GSK to seek FDA approval for Jemperli in small but high-profile cancer use after phase 2 win - Fierce Pharma

FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time - Fierce Pharma

Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector - Fierce Pharma

Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca - Fierce Pharma

FDA takes first step toward ‘de facto’ ad ban: What to know - MM+M - Medical Marketing and Media